基本信息
浏览量:110
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Prof Tergaonkar expertise is in Cancer Cell Signaling & Biology, Genomics, Non-Coding RNAs, Novel anti-cancer strategies, Oncology drug development, Small Molecules, Peptide/siRNA therapeutics. His other research interest includes Patient Derived xenografts and Orphan disease models. His lab studies a transcription factor called NFkB which is a master regulator of inflammation. They focus on identifying targets that will help develop drugs which will block NFkB /inflammation more selectively and not generically hence possibly reducing side effects. In addition, his lab offers genome editing, cryopreservation/ rederivation, gene expression analyses and histology work.
For the excellent work, his lab has received international recognition with the British council development award (2014), the Premiers’ fellowship from Government of South Australia (2015) and University of Macau Distinguished Professorship (2019). Numerous coveted grant funding has also been successfully attained from NRF, BMRC and NMRC over the years. Denome technologies and AVATAMED has been spun off from Prof Tergaonkar’s lab further establishing the direct impact of his work to industry and ultimately, keeping relevant to the needs of the community.
For the excellent work, his lab has received international recognition with the British council development award (2014), the Premiers’ fellowship from Government of South Australia (2015) and University of Macau Distinguished Professorship (2019). Numerous coveted grant funding has also been successfully attained from NRF, BMRC and NMRC over the years. Denome technologies and AVATAMED has been spun off from Prof Tergaonkar’s lab further establishing the direct impact of his work to industry and ultimately, keeping relevant to the needs of the community.
研究兴趣
论文共 229 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jia Feng,You Heng Chuah,Yajing Liang,Nadia Omega Cipta,Yingying Zeng,Tushar Warrier, Gamal Ahmed Rashed Elsayed Elfar,Jeehyun Yoon,Oleg Grinchuk,Emmy Xue Yun Tay, Ker-Zhing Lok, Zong-Qing Zheng,
Nucleic acids research (2024)
Akiko Niibori-Nambu,Chelsia Qiuxia Wang,Desmond Wai Loon Chin,Jing Yuan Chooi,Hiroki Hosoi, Takashi Sonoki,Cheng-Yong Tham,Giselle Sek Suan Nah, Branko Cirovic,Darren Qiancheng Tan,Hitoshi Takizawa, Goro Sashida,
Gene (2024): 148761-148761
Life Sciences (2024): 122818-122818
Trends in cancerno. 1 (2024): 76-91
Lele Wu,Zheng Zhao,Yong Jae Shin,Yiyun Yin,Anandhkumar Raju, Thamil Selvan Vaiyapuri, Khaireen Idzham,Miseol Son,Yeri Lee,Jason K Sa,Joelle Yi Heng Chua,Bilal Unal,
Nature Cell Biologyno. 6 (2024): 1003-1018
Experimental Hematology & Oncologyno. 1 (2024): 1-28
Cell Death & Diseaseno. 3 (2024): 1-12
Dipanwita Das, Upasana Bajaj,Jia Yu Leung, Nurul Fateha Binti Abdul Rashi,Vinay Tergaonkar,Reshma Taneja
Cancer Researchno. 7_Supplement (2024)
Na Wu, Wenhui Zheng, Yundong Zhou, Yu Tian,Min Tang,Xiaoqiang Feng, Milad Ashrafizadeh,Yuzhuo Wang, Xiaojia Niu,Murtaza Tambuwala,Lingzhi Wang,Vinay Tergaonkar,
Ageing Research Reviews (2024): 102428-102428
Experimental hematology & oncologyno. 1 (2024): 68-68
加载更多
作者统计
#Papers: 227
#Citation: 14988
H-Index: 68
G-Index: 120
Sociability: 7
Diversity: 0
Activity: 2
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn